SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-23-004629
Filing Date
2023-07-11
Accepted
2023-07-11 17:00:13
Documents
12
Period of Report
2023-07-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K organicellregen_8k.htm   iXBRL 8-K 22414
  Complete submission text file 0001829126-23-004629.txt   189100

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocel-20230711.xsd EX-101.SCH 3021
3 XBRL LABEL FILE ocel-20230711_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ocel-20230711_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT organicellregen_8k_htm.xml XML 3044
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 231082663
SIC: 2836 Biological Products, (No Diagnostic Substances)